Plasma enterolactone or intestinal Bifidobacterium levels do not explain adenoma formation in multiple intestinal neoplasia (Min) mice fed with two different types of rye-bran fractions

British Journal of Nutrition

Volumn 90, Issue 1, 2003, Pages 119-125

  Oikarinen, Seija ^a   Heinonen, S ^a   Karppinen, S ^b   Matto J ^b   Adlercreutz, H ^a   Poutanen, K ^b   Mutanen, M ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b VTT TECHNICAL RESEARCH CENTRE OF FINLAND   (Finland)

Author keywords

Bifidobacterium; Enterolactone; Lignans; Min mice; Rye bran

Indexed keywords

ENTEROLACTONE; 2,3 BIS(3' HYDROXYBENZYL)BUTYROLACTONE; 2,3-BIS(3'-HYDROXYBENZYL)BUTYROLACTONE; DRUG DERIVATIVE; GAMMA BUTYROLACTONE; LIGNAN; PLANT EXTRACT;

ADENOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GROWTH; BACTERIAL METABOLISM; BACTERIUM DETECTION; BIFIDOBACTERIUM; BLOOD LEVEL; CARCINOGENESIS; COLON ADENOMA; COLONY FORMING UNIT; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY FIBER; DIETARY INTAKE; DISEASE ASSOCIATION; FEMALE; FOOD COMPOSITION; IN VIVO STUDY; INTESTINE FLORA; INTESTINE POLYP; MALE; MOUSE; MULTIPLE CANCER; NONHUMAN; RYE; SMALL INTESTINE TUMOR; SOLUBILITY; STATISTICAL ANALYSIS; TUMOR VOLUME; WEIGHT GAIN; WHEAT BRAN; ANIMAL; BLOOD; C57BL MOUSE; COMPARATIVE STUDY; GENETICS; INTESTINE TUMOR; LARGE INTESTINE; METABOLISM; MICROBIOLOGY; MOUSE MUTANT; RANDOMIZATION; TUMOR SUPPRESSOR GENE;

ACTINOBACTERIA (CLASS); ANIMALIA; BACTERIA (MICROORGANISMS); BIFIDOBACTERIUM; SECALE CEREALE; TRITICUM AESTIVUM; UNCULTURED ACTINOMYCETE;

4-BUTYROLACTONE; ANIMALS; BIFIDOBACTERIUM; DIETARY FIBER; GENES, APC; INTESTINAL NEOPLASMS; INTESTINE, LARGE; LIGNANS; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MODELS, ANIMAL; PLANT EXTRACTS; RANDOM ALLOCATION; SECALE CEREALE;

EID: 0041869320     PISSN: 00071145     EISSN: None     Source Type: Journal    
DOI: 10.1079/BJN2003883     Document Type: Article

References (40)

1. Adlercreutz H (2002) Phyto-estrogens and cancer. The Lancet Oncol 3, 32-41.
2. Adlercreutz H, Wang GJ, Lapcík O, et al. (1998) Time-resolved fluoroimmunoassay for plasma enterolactone. Anal Biochem 265, 208-215.
3. Arimochi H, Kinouchi T, Kataoka K, Kuwahara T & Ohnishi Y (1997) Effect of intestinal bacteria on formation of azoxymethane-induced aberrant crypt foci in the rat colon. Biochem and Biophys Res Commun 238, 753-757.
4. Asp N-G, Johansson C-G, Hallmer H & Siljerström M (1983) Rapid enzymatic assay of insoluble and soluble dietary fibre. J Agric Food Chem 31, 476-482.
5. Beerens H (1990) An elective and selective isolation medium for Bifidobacterium spp. Lett Appl Microbiol 11, 155-157.
6. Bingham SA, Atkinson C, Liggins J, Bluck L & Coward A (1998) Phyto-oestrogens: Where are we now? Br J Nutr 79, 393-406.
7. Challa A, Rao DR, Chawan CB & Chackelford L (1997) Bifidobacterium longum and lactulose suppress azoxymathane-induced colonic aberrant crypt foci in rats. Carcinogenesis 18, 517-521.
8. Crittenden R, Karppinen S, Ojanen S, et al. (2002) In vitro fermentation of cereal dietary fibre carbohydrates by probiotic and intestinal bacteria. J Sci Food Agric 82, 781-789.
9. Davies MJ, Bowey A, Adlercreutz HA, Rowland IR & Rumsby PC (1999) Effects of soy or rye supplementation of high-fat diets on colon tumour development in azoxymethane-treated rats. Carcinogenesis 20, 927-931.
10. Dietrich WF, Lander ES, Smith JS, et al. (1993) Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell 75, 631-639.
11. Douglas SA (1981) A rapid method for the determination of pentosans in wheat flour. Food Chem 7, 139-145.
12. Ferguson LR, Chavan RR & Harris PJ (2001) Changing concepts of dietary fiber: Implications for carcinogenesis. Nutr Cancer 39, 155-169.
13. Good CK, Lasko CM, Adam J & Bird RP (1998) Diverse effect of fish oil on the growth of aberrant crypt foci and tumor multiplicity in F344 rats. Nutr Cancer 31, 204-211.
14. Hardman WE, Cameron IL, Heitman DW & Contreras E (1991) Demonstration of the need for end point validation of putative biomarker - Failure of aberrant crypt foci to predict colon cancer incidence. Cancer Res 5, 6388-6392.
15. Heinonen S, Nurmi T, Liukkonen K, et al. (2001) In vitro metabolism of plant lignans: New precursors of mammalian lignans enterolactone and enterodiol. J Agric Food Chem 49, 3178-3186.
16. Jacobs LR & Lupton JR (1986) Relation between colonic luminal pH, cell proliferation and colon carcinogenesis in 1,2-dimethylhydrazine treated rats fed high fibre diets. Cancer Res 46, 1727-1734.
17. Jenab M & Thompson LU (1996) The influence of flaxseed and lignans on colon carcinogenesis and β-glucuronidase activity. Carcinogenesis 17, 1343-1348.
18. Karppinen S, Kiiliäinen K, Liukkonen K, Forssell P & Poutanen K (2001) Extraction and in vitro fermentation of rye bran fractions. J Cereal Sci 34, 269-278.
19. Karppinen S, Myllymäki O, Forssell P & Poutanen K (2003) Fructan content of rye and rye products. Cereal Chem 80, 168-171.
20. Kitts DD, Yan YV, Wijewickreme AN & Thompson LU (1999) Antioxidant activity of the flaxseed lignan secoisolaricirecinol diaglycoside and its mammalian lignan metabolites enterodiol and enterolactone. Mol Cell Biochem 202, 91-100.
21. McIntyre A, Gibson PR & Young GP (1993) Butyrate production from dietary fibre and protection against large bowel cancer in a rat model. Gut 34, 386-391.
22. Mazur W (1998) Phytoestrogen content in foods. Baillieres Clin Endocrinol Metab 12, 729-742.
23. Mazur W, Fotsis T, Wähälä K, Ojala S, Salakka A & Adlercreutz H (1996) Isotope dilution gas chromatographic-mass spectrometric method for the determination of isoflavonoids, coumesterol and lignans in food samples. Anal Biochem 223, 169-180.
24. Moser AR, Pilot HC & Dove WF (1990) A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 247, 322-324.
25. Min mice: Relation to β-catenin and PCK-isoforms. Carcinogenesis 21, 1167-1173.
26. Min mice. Cancer Lett 161, 253-258.
27. Onoue M, Kado S, Sakaitani Y, Uchida K & Morotomi M (1997) Specific species of intestinal bacteria influence the induction of aberrant crypt foci by 1,2-dimethylhydrazine in rats. Cancer Lett 113, 179-186.
28. Pierre F, Perrin P, Bassonga E, Bornet F, Meflah K & Menanteau J (1999) T cell status influences colon tumor occurrence in Min mice fed short chain fructo-oligosaccharides as a diet supplement. Carcinogenesis 20, 1953-1956.
29. Pierre F, Perrin P, Hamp M, Bornet F, Meflah K & Menanteau J (1997) Short-chain fructo-oligosaccharides reduce the occurrence of colon tumours and develop gut-associated lymphoid tissue in Min mice. Cancer Res 57, 225-228.
30. Reddy BS, Hamid R & Rao C (1997) Effect of dietary oligofructose and inulin on colonic preneoplastic aberrant crypt foci inhibition. Carcinogenesis 18, 1371-1374.
31. Reeves PG, Nielsen FH & Fahey GC Jr (1993) AIN-93 purified diets for laboratory rodents: Final report of the American Institute of Nutrition Ad Hoc Committee on the reformulation of the AIN-76A rodent diet. J Nutr 123, 1939-1951.
32. Rowland IR, Rumney C, Coutts JT & Lievense LC (1998) Effect of Bifidobacterium longum and inulin on gut bacterial metabolism and carcinogen-induced aberrant crypt foci in rats. Carcinogenesis 19, 281-285.
33. Saarinen NM, Huovinen R, Wärri A, et al. (2001) Uptake and metabolism of hydroxymatairesinol in relation to its anticarcinogenenicity in DMBA-induced rat mammary carcinoma model. Nutr Cancer 41, 82-90.
34. Saarinen NM, Wärri A, Mäkelä SI, et al. (2000) Hydroxymatairesinol, a novel enterolactone precursor with antitumor properties from coniferous tree (Picea abies). Nutr Cancer 36, 207-216.
35. Singh J, Rivenson A, Tomita M, et al. (1997) Bifidobacterium longum, a lactic acid-producing intestinal bacterium inhibits colon cancer and modolates the intermediate biomarkers of colon carcinogenesis. Carcinogenesis 18, 833-841.
36. Stumpf K, Uehara M, Nurmi T & Adlercreutz H (2000) Changes in the time-resolved fluoroimmunoassay for plasma enterolactone. Anal Biochem 284, 153-157.
37. Tannock GW (1995) Human Microflora. London: Chapman & Hall.
38. Thompson LU, Seidl MM, Richard SE, Orcheson LJ & Fong HH (1996) Antitumorigenic effect of a mammalian lignan precursor from flaxseed. Nutr Cancer 26, 159-165.
39. Yamada Y, Hata K, Hirose Y, et al. (2002) Microadenomatous lesions involving loss of Apc heterozygosity in the colon of adult ApcMin/+ mice. Cancer Res 62, 6367-6370.
40. Zoran DL, Turner ND, Taddeo SS, Chapkin RS & Lupton JR (1997) Wheat bran diet reduces tumor incidence in a rat model of colon cancer independent of effects on distal luminal butyrate concentrations. J Nutr 127, 2217-2225.